Latest News…

SMC Ltd. Expands Drug Delivery Capabilities with Oval Medical Technologies Acquisition

Somerset, Wisconsin – SMC Ltd., a global contract manufacturer of pharmaceutical and finished medical devices, announced today that it has acquired Oval Medical Technologies Ltd., a specialty pharmaceutical device company developing next generation autoinjectors based in Cambridge, UK.   Oval’s autoinjector platforms address the unmet needs in the self-injection market utilizing both cyclic olefin plastic […]

Continue Reading

Oval Medical Attending Pharmapack Europe (Paris, 10-11 Feb 2016).

Oval Medical representatives Matthew Young (CTO), Pete Evans (Dir. Device Development) and Bastiaan de Leeuw (Dir. Business Development) will attend Pharmapack Europe (Paris, 10-11 Feb 2016). Our autoinjector products will be on display at booth #537 of our Japanese partner company Solize. If you would like to set up an appointment with one of us, […]

Continue Reading

Oval Medical at Biotech Showcase 2016

Barbara Lead (CEO) and Matthew Young (CTO) will be present at Biotech Showcase 2016 from Jan 11th-13th (https://lnkd.in/e7-gUTh) in San Francisco. To arrange to meet them you can contact us via our Contact page.

Continue Reading

Oval Medical represented at Conferences and Events

Oval Medical’s partner Solize Corporation will exhibit and present at the InnoPack 2015 conference in Tokyo (April 22-24th) in conjunction with the CPhI event held at TokyoBigSight. Representatives from Oval and Solize will be present to demonstrate the Oval autoinjectors and collaboration opportunities. Oval Medical has been attending and exhibiting at a number of conferences […]

Continue Reading

Completion of Innovate UK Smart Award

April 2015 Oval Medical completes Innovate UK (formerly The Technology Strategy Board) Smart Award Grant for development of manufacturing equipment for their novel container closure system. Oval Medical has developed bespoke sealing equipment for the drug container in collaboration with 3P Limited; this is a key manufacturing step for its leading edge auto injector. Commenting […]

Continue Reading

Rights Issue

March 2015 Oval Medical recently completed a £1.5m rights issue for the development of the manufacturing process for its novel autoinjector. The autoinjector facilitates the delivery of the new generation of biologics by eliminating issues including glass breakage, drug contamination and variable injection times. This equipment will form part of the manufacturing process for clinical […]

Continue Reading

Oval Medical awarded Innovate UK Proof of Market funding award

November 2014 Oval Medical received £25,000 to contribute to market research for its new, innovative epinephrine autoinjector for the treatment of anaphylactic shock. The incidence of allergies that can cause this serious and potentially fatal reaction is growing worldwide. Oval’s epinephrine autoinjector incorporates the same design philosophy as the first device being used for sumatriptan. […]

Continue Reading

Oval and SOLIZE enter into collaboration on injection device development

Press Release For Immediate Release Cambridge, UK. Monday, 28 April 2014 – Oval Medical Technologies Limited (“Oval”) Oval and SOLIZE enter into collaboration on injection device development. Working together to accelerate product development in the growing auto-injector market. Oval Medical Technologies Ltd (Cambridge, UK) and SOLIZE Corporation (Tokyo, Japan) have agreed to collaborate together in […]

Continue Reading